New tools to bridge the gap between the lab and patients in our update from day 2 of the 2019 HD Therapeutics conference
This fall sees exciting announcements from a number of companies focused on novel Huntingtin Lowering technologies, including Wave, PTC and Voyager
For the first time in HD research, an animal model has been created in pigs using 2 cutting edge DNA editing t
Completely removing normal huntingtin in adults may disrupt healthy brain function, a recent study suggests.
Media reports of a wonder drug for neurodegenerative diseases like Huntington's disease are overhyped
Two recent studies show how a cellular border control system goes wrong in HD, opening new avenues for HD research.
Sheep can help us to identify HD biomarkers and recognize metabolic changes that occur before symptoms develop.
Work with genome editing techniques (zinc fingers and CRISPR) brings these tools closer to use in HD clinical trials
A surprising new mouse study suggests the mutant HD gene may do some of its damage during embryonic development